Skip to main content
SpringerLink
Log in

The Medicines Company is expanding its recall of Cleviprex [clevidipine]

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex That May Contain Particulate Matter. Media Release: 17 Mar 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Medicines Company is expanding its recall of Cleviprex [clevidipine]. React. Wkly. 1294, 3 (2010). https://doi.org/10.2165/00128415-201012940-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012940-00010

Keywords

Search

Navigation